Project leader

Dr. Zoltan Asztalos

Institute presentation

Aktogen Hungary Ltd. is a wholly owned subsidiary of Aktogen Limited, Cambridge, UK. Aktogen aims to accelerate the discovery of drug targets and drugs for the treatment of human mental disorders. The company employs fruit fly, Drosophila m. genetic and pharmacological models of mental disorders for its discoveries. Aktogen has unique capabilities in developing automated fruit fly behaviour systems to effectively test complex behaviour that has relevance to mental disorders.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.